Kim Kardashian Slammed By FDA For Promoting Morning Sickness Pill Diclegis
Kim Kardashian has ticked off the FDA, which says she violated federal drug-promotion rules last month when she promoted Diclegis, a pill that’s used to help morning sickness, on her Instagram page. At the core is that Kardashian and Duschenay Inc., the maker of the drug, failed to alert consumers of the Diclegis’ side effects.
Last month, Kardashian wrote on Twitter and Instagram that she had been suffering from severe morning sickness but had found relief with Diclegis. Alongside a photo of herself holding up the bottle, Kardashian wrote, “OMG. Have you heard about this? As you guys know my #morningsickness has been pretty bad. I tried changing things about my lifestyle, but nothing helped, so I talked to my doctor. He prescribed me #Diclegis, and I felt a lot better and most importantly, it’s been studied and there was no increased risk to the baby.”
Not cool, says the FDA. In a letter posted to its website, the government agency says the reality star’s post violated regulations because she never mentioned any of the drug’s side effects, which include drowsiness. The agency’s letter reads, “The FDA has reviewed the Kim Kardashian Social Media Post. The social media post is false or misleading in that it presents efficacy claims for DICLEGIS, but fails to communicate any risk information.”
Kardashian has since deleted the Instagram post touting Diclegis.